DH News and Press, Definitive Healthcare Corp. From 11/08/21

Definitive Healthcare Corp. (DH) Q3 2021 Earnings Conference Call November 8, 2021, 5:00 PM ET Company Participants Brian Denyeau - ICR, IR Jason Krantz - Founder and CEO Rick Booth - Chief Financial Officer Conference Call Participants Sterling Auty - JP Morgan Craig Hettenbach - Morgan Stan...

(NASDAQ:DH): Q3 Non-GAAP EPS of $0.01 misses by $0.01; GAAP EPS of -$0.09 beats by $0.08. Revenue of $43.08M (+43.3% Y/Y) beats by $1.89M. Press Release For further details see: EPS misses by $0.01, beats on revenue

FRAMINGHAM, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2021. Third Quarter ...

FRAMINGHAM, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial intelligence, today announced it has integrated a range of extensive Asian data sources into Monocl ExpertInsight to provide a deeper understandi...

FRAMINGHAM, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its third quarter ended September 30, 2021 financial results will be released...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy generated positive absolute performance and ...

Life sciences companies can perform rapid, iterative analysis on medical and prescription claims data to develop customized reports that accelerate go-to-market activities Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial intelligen...

Gainers: Protagonist Therapeutics (NASDAQ:PTGX) +82%, Adamas Pharmaceuticals (NASDAQ:ADMS) +74%, Flexion Therapeutics (NASDAQ:FLXN) +62%, Evelo Biosciences (NASDAQ:EVLO) +16%, Progenity (NASDAQ:PROG) +16%. Losers: Voyager Therapeutics (NASDAQ:VYGR)...

Definitive Healthcare has seen a very successful public offering as investors like the role which it plays in a complex healthcare system. I like the role and prospects of the company and while it has good traction on the commercial side, valuations are far too high to be involved her...

Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the closing of its previously announced initial public offering of 17,888,888 shares of its Class A common stock, which includes th...